AI Article Synopsis

  • Physicochemical properties of superparamagnetic iron oxide nanoparticles are critical for their effectiveness as MRI contrast agents.
  • The study examined how electrical charge and molecule length of bisphosphonate coatings affect complement activation and relaxation times in Wistar rats.
  • HEBP-coated nanoparticles exhibited prolonged relaxation times at lower concentrations, even with a higher negative charge, while ammonium group coatings showed weak complement activation across various sizes and concentrations.

Article Abstract

Physicochemical coating properties are often considered to be determining factors for in vivo characteristics of superparamagnetic iron oxide nanoparticles, used as contrast agent in Magnetic Resonance Imaging (MRI). To investigate the electrical charge (modified by zero, one or two ammonium groups) and the molecule length (3, 5 or 7 methylene chains) effects of bisphosphonate-type coatings, we assessed the complement activation, in vivo plasma and tissue relaxation time alterations of intravenously injected small iron oxide nanoparticles (<25 nm) on male healthy Wistar rats. The presence of ammonium groups induces a weak activation of the complement whatever the size and the concentration of particles, whereas hydroxyethylenebisphosphonate (HEBP)-coated particles are poor complement activators only at the lowest concentration. In vivo, HEBP-coated nanoparticles have the greatest prolonged relaxation time effects, despite their higher negative electrical charge, contrary to two ammonium bearing coatings. No significant differences were observed between mono-ammonium molecular coatings.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejps.2013.02.016DOI Listing

Publication Analysis

Top Keywords

iron oxide
12
oxide nanoparticles
12
superparamagnetic iron
8
electrical charge
8
molecule length
8
vitro vivo
4
vivo evaluation
4
evaluation superparamagnetic
4
nanoparticles coated
4
coated bisphosphonates
4

Similar Publications

Biomarkers.

Alzheimers Dement

December 2024

5M Biomed, LLC, Atlanta, GA, USA.

Background: Enriching and detecting Alzheimer's disease (AD) biomarkers in cerebral spinal fluid (CSF) or blood samples are increasingly applied in the AD diagnosis and monitoring of disease progression and treatment response. The accuracy of these processes is dependent on the sensitivity and specificity of capturing and quantifying AD biomarkers, e.g.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

5M Biomed, LLC, Atlanta, GA, USA.

Background: Liquid biopsy for Alzheimer's disease (AD) biomarkers in cerebral spinal fluid (CSF) or blood samples is becoming a significant sector in the management of AD and AD related dementia (ADRD). Whereas different types of molecules, such as small molecules, peptides, and antibodies, have been used as ligands for targeting AD biomarkers/pathologies such as amyloid beta peptides (Aβs), current liquid biopsy approaches mostly use antibodies. However, the activity and affinity of the antibodies can vary depending on the source and preparation as well as the stability in storage.

View Article and Find Full Text PDF

Developing Topics.

Alzheimers Dement

December 2024

Daegu Catholic University, Daegu, Daegu Metropolitan City, Korea, Republic of (South).

Background: The interplaying neuropathology of amyloid plaque, tau tangles, and microglia-driven inflammation (tri-pathology) are related to neuronal and synaptic loss damage in Alzheimer's damages. Interventions that target Aβ or tau individually have not yielded substantial breakthroughs. Iron plays a pivotal role in tri-pathology by protein-bound iron-oxide deposition in amyloid plaque, tau tangle, and microglia, resulting in redox-active toxicity or microglial response induction, such as proinflammatory activation, autophagy dysfunction, and ferroptosis.

View Article and Find Full Text PDF

Background: The metal oxide nanoparticles possess unique properties such as biological compatibility, superior reactivity, and capacity to develop reactive oxygen species, due to this they have drawn significant interest in cancer treatment. The various MONPs such as cerium oxide, Copper oxide, Iron oxide, Titanium dioxide, and Zinc oxide have been investigated for several types of cancers including brain, breast, cervical, colon, leukemia, liver, lung, melanoma, ovarian, and prostate cancers. However, traditional physiochemical synthetic methods for MONPs commonly include toxic materials, a major concern that raises questions regarding their biocompatibility and safety.

View Article and Find Full Text PDF

Introduction: Iron oxide nanozyme was synthesized from the fruit peel extract of pomegranate, which served as a reducing agent during the green synthesis. The scavenging of reactive oxygen species is often accompanied by immunomodulation following antiproliferative effects due to the crosstalk between the proteins involved in the inter-related signaling pathways.

Method: In the current study, the green synthesized nanozyme was studied for its ability to induce apoptosis in breast cancer cell lines.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!